Kate Haviland Net Worth & Insider Trades

Kate Haviland - CHIEF OPERATING OFFICER, Blueprint Medicines Corp

As of March 8, 2022

What is Kate Haviland's Net Worth?

The current estimated net worth of Blueprint Medicines Corp's CHIEF OPERATING OFFICER, Kate Haviland, is estimated to be about $10.61M . Kate Haviland owns about 91,181 units of Blueprint Medicines Corp common stock. In the last 6 years at Blueprint Medicines Corp, Kate Haviland has sold an estimated value of $9.65M worth.

What is Kate Haviland's Past Insider Trading?

Kate Haviland's largest purchase order was 21,644 units , worth over $500.64K on March 5, 2019. Kate Haviland's largest sale order was 21,644 units , worth over $1.84M on March 5, 2019. In total, Kate Haviland has made about 31 transactions over 6 years of their time at Blueprint Medicines Corp. Kate Haviland usually trades in March, with the busiest year in 2017. The most recent transaction was a sale order of 2,767 units , worth over $162.48K on March 8, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Kate Haviland's Salary in 2020?

As CHIEF OPERATING OFFICER of Blueprint Medicines Corp, Kate Haviland has a total base salary of $460,944 . Kate Haviland received compensation valued at about $2,363,556 in 2020 after becoming CHIEF OPERATING OFFICER.

What is Kate Haviland's' Mailing Address?

  • Mailing address is Blueprint Medicines Corporation 38 Sidney Street, Suite 200 Cambridge MA 02139 MA

Blueprint Medicines Corp Executive Compensation

Name
Year
Salary
Total
Jeffrey W. Albers 2020 $645,000 $6,344,667
Jeffrey W. Albers 2019 $590,000 $9,362,371
Jeffrey W. Albers 2018 $541,144 $9,740,799
Michael Landsittel 2020 $379,575 $2,014,974
Michael Landsittel 2019 $345,000 $1,958,720
Michael Landsittel 2018 $281,678 $1,740,610
Fouad Namouni, M.D. 2020 $186,154 $6,668,732
Fouad Namouni, M.D. 2019 - -
Fouad Namouni, M.D. 2018 - -
Kathryn Haviland 2020 $460,944 $2,363,556
Kathryn Haviland 2019 $431,830 $3,090,423
Kathryn Haviland 2018 $392,589 $2,601,762
Tracey L. McCain, Esq. 2020 $453,301 $2,346,428
Tracey L. McCain, Esq. 2019 $437,972 $2,900,568
Tracey L. McCain, Esq. 2018 $425,216 $2,647,962
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm

What are Blueprint Medicines Corp's Past Insider Trades?

Blueprint Medicines Corp's most recent insider trade came on August 10, 2022 by Jeffrey Albers who sold 10,000 units worth $700.7K . In the last 7 years, insiders at Blueprint Medicines Corp have sold an estimated value of $170.05M and bought an estimated value of $17.02M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are Jeffrey Albers,  Ariel Hurley, PRINCIPAL ACCOUNTING OFFICER,  and Kate Haviland, CHIEF OPERATING OFFICER .

Blueprint Medicines Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1